News

The combination of the market's valuation and the lingering economic risks tilts my preference toward raising cash. Read more ...
Q1 2025 Results Conference Call May 7, 2025 2:30 AM ETCompany ParticipantsKarl Hersvik - Chief Executive OfficerDavid Tønne ...
Q1 2025 Earnings Call Transcript May 8, 2025 Royalty Pharma plc beats earnings expectations. Reported EPS is $1.06, ...